{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:18:18Z","timestamp":1791317898612,"version":"4.3.1"},"reference-count":46,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.2217\/imt.13.15","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T10:00:36Z","timestamp":1365069636000},"page":"427-433","source":"Crossref","is-referenced-by-count":42,"title":["Role of Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma: The Clinical and Immunological Sides"],"prefix":"10.1080","volume":"5","author":[{"given":"Alessandro","family":"Pileri","sequence":"first","affiliation":[{"name":"Dermatology, Department of Specialised, Experimental & Diagnostic Medicine, University of Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Delfino","sequence":"additional","affiliation":[{"name":"Department of Surgery & Translational Medicine, Division of Dermatology, University of Florence Medical School, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vieri","family":"Grandi","sequence":"additional","affiliation":[{"name":"Department of Surgery & Translational Medicine, Division of Dermatology, University of Florence Medical School, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pimpinelli","sequence":"additional","affiliation":[{"name":"Department of Surgery & Translational Medicine, Division of Dermatology, University of Florence Medical School, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,4,4]]},"reference":[{"key":"e_1_3_2_3_1_1","unstructured":"Swerdlow SH CampoE HarrisNL et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Geneva Switzerland 270\u2013319 (2008)."},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-184168"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.89.8.1240"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-055749"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.01.025"},{"key":"e_1_3_2_3_7_1","unstructured":"Gudas LJ SpornMB RobertsAB. Cellular biology and biochemistry of the retinoids. In: The Retinoids (2nd Edition). Sporn MB Roberts AB Goodman DS (Eds). Raven Press NY USA 443\u2013520 (1994)."},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70155-8"},{"key":"e_1_3_2_3_9_1","first-page":"15","volume":"8","author":"Zackheim HS","year":"1998","unstructured":"Zackheim HS . Treatment of cutaneous T-cell lymphoma with retinoids. Dermatol. Ther.8 , 15\u201320 (1998).","journal-title":"Dermatol. Ther."},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2006.00083.x"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06360.x"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.1984.tb00631.x"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.9.1131-JFD00001-2-1"},{"key":"e_1_3_2_3_14_1","first-page":"581","article-title":"Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.","volume":"137","author":"Duvic M","year":"2001","unstructured":"Duvic M , MartinAG, KimY et al. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch. Dermatol. 137 , 581\u2013593 (2001).","journal-title":"Arch. Dermatol."},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.9.2456"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.124607"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11156.x"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546630903103980"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.5070\/D30GM267V6"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07901.x"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.06.015"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1359"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09037.x"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.05.010"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)02488-5"},{"key":"e_1_3_2_3_26_1","first-page":"29","volume":"21","author":"Stadler R","year":"2007","unstructured":"Stadler R . Optimal combination with PUVA: rationale and clinical trial update. Oncology (Williston Park)21 , 29\u201332 (2007).","journal-title":"Oncology (Williston Park)"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07975.x"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.06.029"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2011.06.016"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.7.3540"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.5.1824.1824"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006098124087"},{"key":"e_1_3_2_3_33_1","first-page":"5919","article-title":"Abrogation of transforming growth factor-alpha\/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.","volume":"61","author":"Song JI","year":"2001","unstructured":"Song JI , LangoMN, HwangJD et al. Abrogation of transforming growth factor-alpha\/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines. Cancer Res. 61 , 5919\u20135925 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_34_1","first-page":"1234","article-title":"Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action.","volume":"8","author":"Zhang C","year":"2002","unstructured":"Zhang C , HazarikaP, NiX, WeidnerDA et al. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Clin. Cancer Res. 8 , 1234\u20131240 (2002).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03656.x"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03889.x"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.3.315"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20952"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08931.x"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2009.00993.x"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2009.00995.x"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1159\/000305354"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1114"},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2001.tb03708.x"},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.23.4322"},{"key":"e_1_3_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.5.2714"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.13.15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T06:23:28Z","timestamp":1715927008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.13.15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.2217\/imt.13.15"],"URL":"https:\/\/doi.org\/10.2217\/imt.13.15","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}